Prognostic Value of a Clinical Biochemistry-Based Nomogram for Coronavirus Disease 2019

Frontiers in Medicine

Jing Yu¹  Jian Chen²  Lei Nie³  Dongde Wu³  Dongqing Li⁴  Xia Zhou⁵  Zhifeng Yang⁶  Ling Zhang⁷ 

[1] Department of Blood Transfusion, Tongji Medical College, Wuhan No.1 Hospital/Wuhan Hospital of Traditional Chinese and Western Medicine, Huazhong University of Science and Technology, Wuhan, China;Department of Head and Neck Surgery, Tongji Medical College, Hubei Cancer Hospital, Huazhong University of Science and Technology, Wuhan, China;Department of Hepatobiliary Pancreatic Surgery, Tongji Medical College, Hubei Cancer Hospital, Huazhong University of Science and Technology, Wuhan, China;Department of Microbiology Medicine, Wuhan University of Basic Medical of Science, Wuhan, China;Department of Respiratory and Critical Care Medicine, Jinyintan Hospital, Wuhan, China;Department of Thoracic Surgery, Jinyintan Hospital, Wuhan, China;Key Laboratory of Occupational Hazard Identification and Control in Hubei Province, School of Public Health, Wuhan University of Science and Technology, Wuhan, China;

关键词: Coronavirus disease 2019;    inflammatory markers;    carcinoembryonic antigen;    hazard ratio;    prognosis;   

DOI  :  10.3389/fmed.2020.597791

来源: Frontiers

【 授权许可】

CC BY